CompletedNCT00575835
Oral Vitamin D Supplementation in Elderly Women
Phase not reported · 40 planned enrolment
- Countries listed
- 1
- Registry update
- January 8, 2008
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
4,509 matching trial registrations
Showing 4,471–4,500 of 4,509. Every record below meets all the filters shown above.
CompletedNCT00503022
Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration
PHASE1 · 20 planned enrolment
- Countries listed
- 2
- Registry update
- December 28, 2007
TerminatedNCT00492479
An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging
PHASE4 · planned enrolment not reported
- Countries listed
- 1
- Registry update
- December 24, 2007
UnknownNCT00578500
Fertility Preservation by Ovarian and Oocyte Cryopreservation
PHASE2 · PHASE3 · 200 planned enrolment
- Countries listed
- 1
- Registry update
- December 21, 2007
CompletedNCT00132288
MY PALS: A Community-Based Physical Activity Support Program for Older Adults
Phase not reported · 305 planned enrolment
- Countries listed
- 1
- Registry update
- December 19, 2007
CompletedNCT00569569
Retaane® in Age-Related Macular Degeneration
PHASE2 · PHASE3 · 20 planned enrolment
- Countries listed
- 0
- Registry update
- December 7, 2007
UnknownNCT00568191
Stratus Versus Cirrus OCT in AMD
Phase not reported · 100 planned enrolment
- Countries listed
- 1
- Registry update
- December 5, 2007
TerminatedNCT00333476
A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
PHASE2 · 140 planned enrolment
- Countries listed
- 1
- Registry update
- November 28, 2007
TerminatedNCT00089830
A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
PHASE2 · 120 planned enrolment
- Countries listed
- 1
- Registry update
- November 28, 2007
TerminatedNCT00139282
A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration
PHASE3 · planned enrolment not reported
- Countries listed
- 1
- Registry update
- November 28, 2007
CompletedNCT00465153
The Combined Effects of Resistance Training and Flax Oil Supplementation Upon Inflammation in Older Adults
PHASE3 · 60 planned enrolment
- Countries listed
- 1
- Registry update
- November 5, 2007
UnknownNCT00533754
Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population
Phase not reported · planned enrolment not reported
- Countries listed
- 1
- Registry update
- September 21, 2007
UnknownNCT00174135
Sarcopenia Studies for the Elderly Population in Taiwan
Phase not reported · 100 planned enrolment
- Countries listed
- 1
- Registry update
- August 30, 2007
UnknownNCT00148551
Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.
PHASE2 · PHASE3 · 120 planned enrolment
- Countries listed
- 1
- Registry update
- July 30, 2007
CompletedNCT00140803
Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration
PHASE2 · 106 planned enrolment
- Countries listed
- 2
- Registry update
- July 12, 2007
CompletedNCT00485043
Effects of Modified T'ai Chi on Symptoms in Older Adults With Osteoarthritis
PHASE1 · 30 planned enrolment
- Countries listed
- 0
- Registry update
- June 12, 2007
CompletedNCT00473902
Older Adult Training Study With Creatine and CLA
Phase not reported · 39 planned enrolment
- Countries listed
- 1
- Registry update
- May 16, 2007
CompletedNCT00150202
Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
PHASE3 · 90 planned enrolment
- Countries listed
- 1
- Registry update
- May 7, 2007
CompletedNCT00211484
Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.
PHASE2 · 5 planned enrolment
- Countries listed
- 1
- Registry update
- May 7, 2007
UnknownNCT00463411
Study of Male Osteoporosis and Aging
Phase not reported · 30,000 planned enrolment
- Countries listed
- 1
- Registry update
- April 20, 2007
UnknownNCT00354445
A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD
PHASE4 · 1,000 planned enrolment
- Countries listed
- 1
- Registry update
- January 15, 2007
TerminatedNCT00312351
A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)
PHASE4 · 262 planned enrolment
- Countries listed
- 1
- Registry update
- January 15, 2007
TerminatedNCT00134667
Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)
PHASE4 · 360 planned enrolment
- Countries listed
- 1
- Registry update
- January 15, 2007
UnknownNCT00370539
Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD
PHASE3 · planned enrolment not reported
- Countries listed
- 1
- Registry update
- November 14, 2006
CompletedNCT00344227
Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)
PHASE2 · 40 planned enrolment
- Countries listed
- 1
- Registry update
- June 26, 2006
CompletedNCT00135837
Photodynamic Therapy in Occult-Only Lesions (POOL)
PHASE4 · 202 planned enrolment
- Countries listed
- 1
- Registry update
- June 21, 2006
UnknownNCT00032396
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
PHASE2 · planned enrolment not reported
- Countries listed
- 1
- Registry update
- May 29, 2006
CompletedNCT00321997
A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.
PHASE2 · PHASE3 · 540 planned enrolment
- Countries listed
- 0
- Registry update
- May 4, 2006
CompletedNCT00087763
Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)
PHASE2 · 135 planned enrolment
- Countries listed
- 0
- Registry update
- May 3, 2006
CompletedNCT00215670
Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)
PHASE2 · PHASE3 · 125 planned enrolment
- Countries listed
- 0
- Registry update
- May 3, 2006